Indian Journal of Nephrology Home 

EDIRORIAL
[Download PDF]
Year : 2022  |  Volume : 32  |  Issue : 6  |  Page : 525-

Bid Adieu……

Sanjay Kumar Agarwal 
 Editor in Chief, Professor and Head, Department of Nephrology, AIIMS, New Delhi - 110 029, India

Correspondence Address:
Sanjay Kumar Agarwal
Editor in Chief, Professor and Head, Department of Nephrology, AIIMS, New Delhi - 110 029
India

How to cite this article:
Agarwal SK. Bid Adieu…….Indian J Nephrol 2022;32:525-525

How to cite this URL:
Agarwal SK. Bid Adieu……. Indian J Nephrol [serial online] 2022 [cited 2023 Jan 28 ];32:525-525
Available from: https://www.indianjnephrol.org/text.asp?2022/32/6/525/364084

Full Text

[AUTHOR:1]

The issue of Indian Journal of Nephrology you are now reading is the last one I will be editing. It has been a long journey of 7 years since I first edited the journal's issue which appeared in July-Aug 2016. For me, errorless publishing of the manuscripts was the most important issue. To make it possible, in addition to author's own checking a document's version before PDF proof reading by me, a PDF rechecking was made mandatory in which all deputy and associate editors contributed tirelessly. I hope I could succeed in my aim.

Publishing a scientific journal at timely intervals and with all the sections with little or no error was not an easy task, at least for me. Throughout these 7 years, I was lucky to have excellent support from my deputy editors, Prof. Dipankar Bhowmik and Prof. Soumita Bagchi, and associate editors, Prof (s) Gopalakrishnan, Sree Bhushan Raju, Narayan Prasad, Manish Rathi, and Santosh Verughese, representing all major institutions of India. All were excellent academicians, and despite being very busy clinicians in their own institutions, they contributed to IJN, going out of way from their busy schedules.

There was always a challenge to increase IJN frequency from bimonthly to monthly and this had been one of the issues in every governing body of society related to IJN. I was more in favor of having quality manuscripts rather than increasing the number of manuscripts and thus increased frequency of IJN. IJN usually received 500-600 manuscripts for submission yearly and with the rejection rate being somewhat 60%-70%, we were left to have ~150 accepted manuscripts, which were not sufficient to increase the frequency of IJN on a monthly basis.

One additional component of the IJN which I thought should come out was the "abstracts" presented in society annual conference. These are the works which residents, younger colleagues, and even senior colleagues present in annual meetings, but many of them were never published in Index journals and therefore could not be traced. In 2016, after taking over as the chief editor, I thought this aspect of research was important, and since then, yearly, a supplement of presentation of annual conference has been brought as a supplement of the Nov-Dec issue of IJN.

I could not succeed in bringing out many supplements during my tenure. However, still, we could publish the following: Kidney-paired donation to increase living donor kidney transplantation in India: Guidelines of Indian Society of Organ Transplantation - 2017 (Jan-Feb 2018), Symposium on COVID-19 and kidney diseases (May-June 2020), HD guidelines (July 2020), NOTTO transplant specific guidelines with reference to COVID-19 (July- Aug2020), KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention and prevention of chronic kidney disease-mineral and bone disorder (CKDMBD): Indian commentary (July-Aug 2020), NOTTO COVID-19 vaccine guidelines for transplant recipients (March-April 2021), CAPD peritonitis guidelines - Consensus statement of Peritoneal Dialysis Society of India - 2020 (Sep-Oct 2021), and ISOT consensus statement for the kidney transplant recipient and living donor with a previous diagnosis of COVID-19 (July-Aug 2022).

The new editorial team will start work with the January 2023 issue. I am sure IJN will continue to provide the nephrology community a valuable resource. My best wishes for the new team!

I thank Medknow and lately Wolters Kluwer India for publishing IJN. However, making the website user friendly and for timely publishing, they need to do lot of work for improvement; otherwise, many authors will think twice while sending their work for publication in IJN.

I also thank reviewers, deputy and associate editors, and editorial board members for making IJN a part of their professional lives.

Most of all, I thank all authors for producing outstanding material for no reward, other than the desire to educate their colleagues and improve the care we provide to our patients. That is, after all, our mission, and I have been honored to play a role in achieving it for the last 7 years.